Mobidiag develops and provides molecular diagnostics for infectious diseases and antibiotic resistances.
Our goal is to make in vitro diagnostics fast, accurate and accessible to improve quality and efficiency of healthcare systems, help prevent the spreading of antibiotic resistances and create new opportunities for implementing diagnostics in routine.
At Mobidiag, we have harnessed our existing technologies and expertise to rapidly develop and supply two coronavirus molecular diagnostic tests. As a result, this global solution provides clinicians with a complete solution suited for their own laboratory needs and capacities.
Novodiag® is providing rapid and sensitive on-demand results. With its wide panel offer, the fully automated Novodiag platform is ideal for complementing high-throughput screening solutions for immediate detection of infectious diseases when time-to-result is critical.
Watch Novodiag® in action.
Amplidiag® is a family of diagnostic tests for high-volume screening of infectious diseases and antibiotic resistances. Take the Amplidiag amplification kits even further by automating the workflow from primary sample to final result with Amplidiag® Easy.
Watch Amplidiag® Easy in action!
